Bisphosphonates Billing & Prior-Auth Playbook
A prescriber-level guide to bisphosphonate pharmacology, indication coding, prior authorization strategy, and step-therapy navigation for alendronate, risedronate, zoledronic acid, and ibandronate.
Bisphosphonates: Drug Class Monograph
6 source-based articles maintained by the HealthRX.com Editorial Team.
6articles
4topic areas covered
Jan 15, 2025latest review
Bisphosphonates: Drug Class Monograph library
Showing 6 of 6 clinical reviews.
Bisphosphonates Class Overview Monograph
A prescriber-level monograph covering bisphosphonate pharmacology, dosing, efficacy data, adverse effects, monitoring, and clinical decision points for osteoporosis management.
Bisphosphonates Drug-Drug Interaction Table: A Complete Prescriber Reference
A clinical-level review of bisphosphonate drug-drug interactions, pharmacokinetics, dosing rules, and prescribing guidance for alendronate, zoledronic acid, risedronate, ibandronate, and pamidronate, with a full DDI table and primary-source citations.
Bisphosphonates Monitoring Bundle: Labs, Imaging, and Follow-Up Schedules for Prescribers
A prescriber-level guide to bisphosphonate monitoring, covering baseline labs, on-treatment surveillance, renal function tracking, dental screening, and when to consider a drug holiday.
Bisphosphonates Special-Populations Summary: Prescribing Across Renal, Geriatric, Pediatric, and Reproductive Subgroups
A clinician-focused summary of bisphosphonate prescribing in special populations including renal impairment, geriatric patients, premenopausal women, pediatric use, and pregnancy. Includes dose adjustments, monitoring, and contraindications.
Bisphosphonates: How to Select the Right Agent Within the Class
A prescriber-level guide to choosing between alendronate, risedronate, ibandronate, zoledronic acid, and pamidronate based on indication, renal function, adherence profile, and fracture-reduction evidence.
